Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus, Type 2 × alogliptin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1

Interventions

relacorilant 5 Pioglitazone 4 Metformin 4 Sitagliptin Phosphate 3 saxagliptin 2 Vildagliptin 2 Sulfonylurea Compounds 2 Rosiglitazone 2 Resistance Training 2 Nutritional Status 2 Dipeptidyl-Peptidase IV Inhibitors 2 Blood Specimen Collection 2 voglibose 1 somapacitan 1 semaglutide 1 repaglinide 1 pembrolizumab 1 miglitol 1 metahexamide 1 meglitinide 1 mazdutide 1 glymidine 1 glisoxepide 1 gliquidone 1 glimepiride 1 glibornuride 1 dapagliflozin 1 alogliptin 1 Urine Specimen Collection 1 Troglitazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01588587 2012-10-19

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Nagaoka Red Cross Hospital

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡